Private Advisor Group LLC Reduces Stock Holdings in The Clorox Company (NYSE:CLX)
Private Advisor Group LLC Reduces Stock Holdings in The Clorox Company (NYSE:CLX)
Private Advisor Group LLC decreased its stake in The Clorox Company (NYSE:CLX – Get Rating) by 3.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 31,236 shares of the company's stock after selling 1,235 shares during the quarter. Private Advisor Group LLC's holdings in Clorox were worth $1,452,614,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Federated Hermes Inc. lifted its stake in shares of Clorox by 86.2% during the 2nd quarter. Federated Hermes Inc. now owns 1,945,898 shares of the company's stock worth $274,332,000 after acquiring an additional 901,040 shares during the last quarter. State Street Corp lifted its stake in shares of Clorox by 9.6% during the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company's stock worth $1,255,721,000 after acquiring an additional 778,269 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Clorox by 5.6% during the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock worth $1,407,673,000 after acquiring an additional 580,982 shares during the last quarter. Two Sigma Investments LP raised its position in Clorox by 4,186.6% during the 3rd quarter. Two Sigma Investments LP now owns 303,622 shares of the company's stock valued at $38,982,000 after purchasing an additional 296,539 shares in the last quarter. Finally, Invesco Ltd. raised its position in Clorox by 38.2% during the 1st quarter. Invesco Ltd. now owns 1,051,679 shares of the company's stock valued at $146,216,000 after purchasing an additional 290,833 shares in the last quarter. Hedge funds and other institutional investors own 79.12% of the company's stock.
Get Clorox alerts:Clorox Stock Up 1.9 %
Shares of CLX stock opened at $157.50 on Monday. The Clorox Company has a 1-year low of $120.50 and a 1-year high of $160.59. The stock's fifty day moving average price is $150.56 and its 200 day moving average price is $144.95. The company has a debt-to-equity ratio of 5.04, a current ratio of 0.86 and a quick ratio of 0.47. The company has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a price-to-earnings-growth ratio of 3.12 and a beta of 0.29.
Clorox (NYSE:CLX – Get Rating) last announced its earnings results on Thursday, February 2nd. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.32. Clorox had a return on equity of 89.97% and a net margin of 6.16%. The firm had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.66 billion. During the same period in the previous year, the business earned $0.66 EPS. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 4.23 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be paid a dividend of $1.18 per share. The ex-dividend date of this dividend is Tuesday, April 25th. This represents a $4.72 annualized dividend and a yield of 3.00%. Clorox's dividend payout ratio (DPR) is 134.86%.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research report on Friday, January 13th. Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $152.00 to $147.00 in a research report on Monday, March 20th. StockNews.com initiated coverage on Clorox in a research report on Thursday, March 16th. They set a "hold" rating for the company. UBS Group boosted their price target on Clorox from $129.00 to $140.00 in a research report on Friday, February 3rd. Finally, Raymond James boosted their price target on Clorox from $160.00 to $165.00 and gave the stock an "outperform" rating in a research report on Friday, February 3rd. Seven analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $141.00.
Clorox Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Recommended Stories
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/20 – 3/24
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
根據Private Advisor Group LLC在最近提交給美國證券交易委員會的13F文件中稱,第四季度該公司在The Clorox Company (NYSE:CLX - Get Rating)的股份減少了3.8%。該公司在本季度賣出1,235股後,擁有31,236股該公司的股票。在最近的報告期結束時,Private Advisor Group LLC在Clorox的持股價值爲1,452,614,000美元。
其他一些機構投資者和對沖基金最近也修改了該股的持有量。聯邦愛馬仕公司在第二季度將其在高樂氏的股份提高了86.2%。聯邦愛馬仕公司在上個季度又收購了901,040股股票後,現在擁有該公司1,945,898股股票,價值274,332,000美元。State Street Corp在第二季度將其在Clorox的股份上調了9.6%。State Street Corp在上個季度又收購了778,269股股票後,現在擁有該公司8,907,083股股票,價值1,255,721,000美元。貝萊德公司在第三季度將其在Clorox的股份上調了5.6%。貝萊德公司在上個季度又收購了580,982股股票後,現在擁有該公司10,964,049股股票,價值1407,673,000美元。Two Sigma Investments LP在第三季度將其在高樂氏的頭寸提高了4,186.6%。Two Sigma Investments LP在上個季度又購買了296,539股股票後,現在擁有該公司303,622股股票,價值38,982,000美元。最後,景順有限公司在第一季度將其在高樂氏的頭寸提高了38.2%。景順有限公司在上個季度又購買了290,833股股票後,現在擁有該公司1,051,679股股票,價值146,216,000美元。對沖基金和其他機構投資者擁有該公司79.12%的股票。
獲取 Clorox 警報:
高樂氏股票上漲1.9%
週一,CLX股票開盤價爲157.50美元。高樂氏公司創下1年低點120.50美元,1年高點160.59美元。該股的五十天移動平均價格爲150.56美元,其200天移動平均線價格爲144.95美元。該公司的債務與權益比率爲5.04,流動比率爲0.86,速動比率爲0.47。該公司的市值爲194.6億美元,市盈率爲45.00,市盈增長率爲3.12,beta值爲0.29。
Clorox(紐約證券交易所代碼:CLX — Get Rating)上次公佈財報是在2月2日星期四。該公司報告本季度每股收益0.98美元,比市場普遍預期的0.66美元高出0.32美元。高樂氏的股本回報率爲89.97%,淨利潤率爲6.16%。該公司本季度的收入爲17.2億美元,而市場普遍預期爲16.6億美元。去年同期,該業務的每股收益爲0.66美元。該公司本季度的收入同比增長1.4%。研究分析師平均預計,Clorox公司將在本財年公佈每股收益4.23美元。
高樂氏宣佈分紅
該公司最近還宣佈了季度股息,該股息將於5月12日星期五支付。4月26日星期三登記在冊的投資者將獲得每股1.18美元的股息。本次股息的除息日爲4月25日星期二。這意味着年化股息爲4.72美元,收益率爲3.00%。高樂氏的股息支付率(DPR)爲134.86%。
華爾街分析師權衡一下
許多股票研究分析師都對該公司進行了權衡。摩根大通在1月13日星期五的一份研究報告中將高樂氏的目標價格從126.00美元上調至135.00美元,並給該公司 “減持” 評級。德意志銀行Aktiengesellschaft在3月20日星期一的一份研究報告中將高樂氏的目標價格從152.00美元下調至147.00美元。StockNews.com在3月16日星期四的一份研究報告中開始報道高樂氏。他們爲公司設定了 “持有” 評級。瑞銀集團在2月3日星期五的一份研究報告中將高樂氏的目標股價從129.00美元上調至140.00美元。最後,雷蒙德·詹姆斯在2月3日星期五的一份研究報告中將高樂氏的目標股價從160.00美元上調至165.00美元,並將該股評爲 “跑贏大盤”。七位分析師對該股進行了賣出評級,六位分析師給出了持有評級,一位給出了該公司的股票買入評級。根據MarketBeat的數據,高樂氏目前的共識評級爲 “持有”,共識目標價爲141.00美元。
高樂氏簡介
(獲取評級)
Clorox Co從事消費品和專業產品的製造和銷售。它通過以下業務領域運營:健康與保健、家居、生活方式和國際業務。健康與保健部門包括清潔產品、專業產品和維生素、礦物質和補品,主要在美國銷售和銷售。
推薦故事
免費獲取 StockNews.com 關於高樂氏 (CLX) 的研究報告的副本
MarketBeat Week 回顧 — 3 月 20 日 — 3 月 24 日
Diversion King 原裝零件公司在利潤指導上
埃森哲已經觸底了
2023 年 11 只最佳非必需消費品股
5 只最佳股息捕獲股票
接收 Clorox Daily 的新聞和評級 -在下面輸入您的電子郵件地址,即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Clorox及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧